Can targeted programmed death-1 antibody be a new treatment approach in breast cancer
Sendur, M.A.N.; Aksoy, S.; Demirci, S.; Ozdemir, N.Y.; Zengin, N.; Altundag, K.
Journal of BUON Official Journal of the Balkan Union of Oncology 19(2): 584
2014
ISSN/ISBN: 1107-0625 PMID: 24965433 Document Number: 675734
Document emailed within 1 workday
Related Documents
Smeland, E.B. 1992: Programmed cell death--significance for cancer etiology and treatment Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(12): 1567Lehr, H.-A.; Schaefer, S.C.; Delaloye, J.-F.ço. 2009: Predictive value of Her2/neu expression/amplification for the targeted treatment of breast cancer Revue Medicale Suisse 5(211): 1525-1529
Zhang, S.; Wang, L.; Li, M.T.; Zeng, X.F.; Zhang, F.C. 2019: The role of programmed death receptor-1/programmed death receptor-1 ligands pathway in autoimmune diseases Zhonghua Nei Ke Za Zhi 58(8): 620-624
Heinzl, S. 2000: Trastuzumab. Monoclonal antibody for the treatment of breast cancer Medizinische Monatsschrift für Pharmazeuten 23(11): 350-352
Abe, H.; Kuroki, M.; Tachibana, K.; Li, T.; Awasthi, A.; Ueno, A.; Matsumoto, H.; Imakiire, T.; Yamauchi, Y.; Yamada, H.; Ariyoshi, A.; Kuroki, M. 2002: Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen Anticancer Research 22(3): 1575-1580
Abdulrahman Jnr, G.O. 2015: Targeted therapies in the management of breast cancer Gulf Journal of Oncology 1(19): 38-43
Furuya, Y.; Lundmo, P.; Short, A.D.; Gill, D.L.; Isaacs, J.T. 1994: The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin Cancer Research 54(23): 6167-6175
Jerzak, K.J.; Raphael, J.; Desautels, D.N.; Blanchette, P.S.; Tyono, I.; Pritchard, K.I. 2018: Bone-Targeted Therapy in Early Breast Cancer Oncology 32(11): 562-569
Jacob, A.; Mathew, A. 2016: Optimal use of Bone-Targeted Agents in Breast Cancer Oncology 30(8): 703-704
Piacentini, M.; Fesus, L.; Farrace, M.G.; Ghibelli, L.; Piredda, L.; Melino, G. 1991: The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis) European Journal of Cell Biology 54(2): 246-254
Chakraborty, M.; Mukerjee, S.; Foon, K.A.; Köhler, H.; Ceriani, R.L.; Bhattacharya-Chatterjee, M. 1995: Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody Cancer Research 55(7): 1525-1530
Sheng, J.; Samten, B.K.; Xie, S.S.; Wei, S.L. 1995: Study on the specific killing activity of albumin nanoparticles containing adriamycin targeted by monoclonal antibody BDI-1 to human bladder cancer cells Yao Xue Xue Bao 30(9): 706-710
Singer, C.F.; Hudelist, G.; Galid, A.; Kubista, E. 2003: Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment Drugs of Today 39(12): 917-926
Okano, M.; Ohtake, T.; Saji, S. 2016: Combination Therapy of Molecular-Targeted Drugs for Breast Cancer -- their Potential in the Future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(4): 398-403
2011: Categorization of triple-negative breast cancer patients will help in targeted therapy selection Oncology 25(9): 849
Ormenisan, C.; Kubik, M.; Legrand, S.; Kraemer, D.; Smotherman, C.; Masood, S. 2015: The potential of ki67 and p53 assessment in development of individualized targeted therapy in breast cancer patients Pathologica 107(3-4): 177-180
Murray, J.L.; Macey, D.J.; Grant, E.J.; Rosenblum, M.G.; Kasi, L.P.; Zhang, H.Z.; Katz, R.L.; Riger, P.T.; LeBherz, D.; Bhadkamkar, V. 1995: Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment Cancer Research 55(23 Suppl): 5925s-5928s
Guan, H-tao.; Xue, X-huan.; Wang, X-jing.; Li, A.; Qin, Z-yin. 2006: Effects of siRNA targeted to survivin in suppressing proliferation and inducing apoptosis in breast cancer MCF-7 cells Zhonghua Zhong Liu Za Zhi 28(5): 326-330
Hengartner, M.O.; Hengartner, M.O. 1995: Pharmacia Biotech & Science prize. Grand prize winner. Life and death decisions: ced-9 and programmed cell death in Caenorhabditis elegans Science 270(5238): 930-931
Gao, J.; Isaacs, J.T. 1998: Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells Cancer Research 58(15): 3299-3306